Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Purdue OTCs

This article was originally published in The Tan Sheet

Executive Summary

Stamford, Conn.-based firm announces resumed shipment of several OTC product lines after manufacturing difficulties, including Betadine microbicides, Colace stool softeners, Gentlax Tablets and Slow-Mag Tablets. "We are working hard to ensure that our full line of OTC products is back on the market and actively promoted as soon as possible, including the Senokot Laxative family of products," said Steve Seid, Exec Director-National Accounts & Trade Relations Feb. 22. Purdue acquired Colace and Slow-Mag last year to bolster consumer health business (1"The Tan Sheet" Jan. 6, 2003, p. 12)...

You may also be interested in...



Colace, Slow-Mag Buy Part Of Purdue Consumer Health Growth Plan

Purdue Pharma's acquisition of the Colace stool softener, Peri-Colace laxative capsule and Slow-Mag dietary supplement brands from Shire Pharmaceuticals Group is part of the firm's strategy to grow and diversify its consumer health business

Mylan Symbicort Trial Looms As Company Eyes First US Generic

A trial will begin next month in Mylan’s bid to overcome patents shielding AstraZeneca’s Symbicort respiratory brand in the US. With rival Teva having previously settled ANDA action, Mylan is in the driving seat for a first substitutable generic.

Can RFID Tags Give Generics Companies An Edge?

Fresenius Kabi’s decision to add radio frequency-identification (RFID) tags to 24 products used in hospital operating rooms will help the company’s hospital pharmacy customers reduce waste, increase efficiencies and facilitate tighter medication inventory control, executives claim. However, only 10% of US hospitals are currently equipped to scan and process RFID tags, despite larger adoption rates in other industry sectors. COVID-19-related revenue losses may push more hospitals to adopt automated RFID medication management systems to save time and reduce labor costs.

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel